Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: an European organisation for research and treatment of cancer soft tissue and bone sarcoma group randomised phase II and pharmacogenetic study

Saved in:
Bibliographic Details
Other Authors: Gelderblom, Hans R. (Other) , Hohenberger, Peter (Other)
Format: Article (Journal)
Language:English
Published: 2014
In: European journal of cancer
Year: 2014, Volume: 50, Issue: 2, Pages: 388-396
ISSN:1879-0852
DOI:10.1016/j.ejca.2013.10.002
Online Access:Resolving-System, Volltext: http://www.ncbi.nlm.nih.gov/pubmed/24469382
Verlag, Volltext: http://dx.doi.org/10.1016/j.ejca.2013.10.002
Get full text
Author Notes:Gelderblom, H ... Hohenberger, P.

MARC

LEADER 00000caa a2200000 c 4500
001 1485186447
003 DE-627
005 20230426121438.0
007 cr uuu---uuuuu
008 141007s2014 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ejca.2013.10.002  |2 doi 
035 |a (DE-627)1485186447 
035 |a (DE-576)415186447 
035 |a (DE-599)BSZ415186447 
035 |a (OCoLC)1340650979 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
245 0 0 |a Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma  |b an European organisation for research and treatment of cancer soft tissue and bone sarcoma group randomised phase II and pharmacogenetic study  |c Gelderblom, H ... Hohenberger, P. 
264 1 |c 2014 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 07.10.2014 
700 1 |a Gelderblom, Hans R.  |d 1939-  |0 (DE-588)173451489  |0 (DE-627)698365429  |0 (DE-576)134297288  |4 oth 
700 1 |a Hohenberger, Peter  |d 1953-  |0 (DE-588)1025311469  |0 (DE-627)72202875X  |0 (DE-576)370195574  |4 oth 
773 0 8 |i In  |t European journal of cancer  |d Amsterdam [u.a.] : Elsevier, 1992  |g 50(2014), 2, Seite 388-396  |w (DE-627)266883400  |w (DE-600)1468190-0  |w (DE-576)090954173  |x 1879-0852  |7 nnas  |a Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma an European organisation for research and treatment of cancer soft tissue and bone sarcoma group randomised phase II and pharmacogenetic study 
773 1 8 |g volume:50  |g year:2014  |g number:2  |g pages:388-396  |g extent:9  |a Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma an European organisation for research and treatment of cancer soft tissue and bone sarcoma group randomised phase II and pharmacogenetic study 
856 4 0 |u http://www.ncbi.nlm.nih.gov/pubmed/24469382  |x Resolving-System  |3 Volltext 
856 4 0 |u http://dx.doi.org/10.1016/j.ejca.2013.10.002  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20141007 
993 |a Article 
994 |a 2014 
998 |g 1025311469  |a Hohenberger, Peter  |m 1025311469:Hohenberger, Peter  |d 60000  |d 61800  |e 60000PH1025311469  |e 61800PH1025311469  |k 0/60000/  |k 1/60000/61800/  |p 16  |y j 
999 |a KXP-PPN1485186447  |e 2817062973 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"subtitle":"an European organisation for research and treatment of cancer soft tissue and bone sarcoma group randomised phase II and pharmacogenetic study","title":"Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma","title_sort":"Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma"}],"name":{"displayForm":["Gelderblom, H ... Hohenberger, P."]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"9 S."}],"language":["eng"],"recId":"1485186447","note":["Gesehen am 07.10.2014"],"person":[{"given":"Hans R.","family":"Gelderblom","display":"Gelderblom, Hans R.","role":"oth"},{"given":"Peter","family":"Hohenberger","display":"Hohenberger, Peter","role":"oth"}],"id":{"doi":["10.1016/j.ejca.2013.10.002"],"eki":["1485186447"]},"origin":[{"dateIssuedDisp":"2014","dateIssuedKey":"2014"}],"relHost":[{"corporate":[{"display":"European Organization for Research on Treatment of Cancer","roleDisplay":"Herausgebendes Organ","role":"isb"},{"roleDisplay":"Herausgebendes Organ","role":"isb","display":"European Association for Cancer Research"},{"display":"European School of Oncology","role":"isb","roleDisplay":"Herausgebendes Organ"}],"language":["eng"],"recId":"266883400","note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"],"disp":"Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma an European organisation for research and treatment of cancer soft tissue and bone sarcoma group randomised phase II and pharmacogenetic studyEuropean journal of cancer","type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"extent":"9","year":"2014","pages":"388-396","volume":"50","issue":"2","text":"50(2014), 2, Seite 388-396"},"origin":[{"dateIssuedDisp":"1992-","publisher":"Elsevier ; Pergamon Press","publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]","dateIssuedKey":"1992"}],"id":{"zdb":["1468190-0"],"issn":["1879-0852"],"eki":["266883400"]},"title":[{"title_sort":"European journal of cancer","title":"European journal of cancer"}],"titleAlt":[{"title":"EJC online"}],"pubHistory":["28.1992 -"]}]} 
SRT |a BROSTALLIC2014